Monday, October 24, 2016

Neurontin


Neurontin is a brand name of gabapentin, approved by the FDA in the following formulation(s):


NEURONTIN (gabapentin - capsule; oral)



  • Manufacturer: PFIZER PHARMS

    Approval date: December 30, 1993

    Strength(s): 100MG [AB], 300MG [AB], 400MG [RLD][AB]

NEURONTIN (gabapentin - solution; oral)



  • Manufacturer: PARKE DAVIS

    Approval date: March 2, 2000

    Strength(s): 250MG/5ML [RLD][AA]

NEURONTIN (gabapentin - tablet; oral)



  • Manufacturer: PFIZER PHARMS

    Approval date: October 9, 1998

    Strength(s): 600MG [AB], 800MG [RLD][AB]

Has a generic version of Neurontin been approved?


A generic version of Neurontin has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Neurontin and have been approved by the FDA:


gabapentin capsule; oral



  • Manufacturer: ACTAVIS ELIZABETH

    Approval date: September 12, 2003

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: ALKEM

    Approval date: December 17, 2010

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: AMNEAL PHARMS NY

    Approval date: July 25, 2007

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: APOTEX INC

    Approval date: April 6, 2005

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: AUROBINDO PHARM

    Approval date: January 31, 2008

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: HIKMA

    Approval date: September 25, 2007

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: INVAGEN PHARMS

    Approval date: December 30, 2009

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: MARKSANS PHARMA

    Approval date: July 21, 2011

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: MYLAN

    Approval date: February 14, 2011

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: RANBAXY

    Approval date: October 7, 2005

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: SUN PHARM INDS LTD

    Approval date: August 24, 2006

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: TEVA PHARMS

    Approval date: October 8, 2004

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: May 11, 2007

    Strength(s): 100MG [AB], 300MG [AB], 400MG [AB]

gabapentin solution; oral



  • Manufacturer: HI TECH PHARMA

    Approval date: February 18, 2011

    Strength(s): 250MG/5ML [AA]

gabapentin tablet; oral



  • Manufacturer: ACTAVIS ELIZABETH

    Approval date: October 21, 2004

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: APOTEX INC

    Approval date: September 13, 2006

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: AUROBINDO PHARMA LTD

    Approval date: October 6, 2011

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: GLENMARK GENERICS

    Approval date: August 18, 2006

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: HIKMA PHARMS

    Approval date: July 21, 2011

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: IVAX SUB TEVA PHARMS

    Approval date: April 29, 2005

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: MATRIX LABS LTD

    Approval date: June 1, 2010

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: SUN PHARM INDS LTD

    Approval date: August 24, 2006

    Strength(s): 600MG [AB], 800MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: February 11, 2011

    Strength(s): 600MG [AB], 800MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Neurontin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Lactam-free amino acids
    Patent 6,054,482
    Issued: April 25, 2000
    Inventor(s): Augart; Helmut & Gebhardt; Uwe & Herrmann; Wolfgang
    Assignee(s): Godecke Aktiengesellschaft
    The present invention concerns cyclic amino acids of formula ##STR1## substantially free from the lactam ##STR2## wherein n is an integer of from 4 to 6, a process for the preparation thereof, compositions containing the compounds and methods of using them.
    Patent expiration dates:

    • April 25, 2017


    • October 25, 2017
      ✓ 
      Pediatric exclusivity




  • Liquid pharmaceutical compositions
    Patent 7,256,216
    Issued: August 14, 2007
    Inventor(s): Kulkarni; Neema M. & Schneider; Michael & Silbering; Steven B. & Meyer-Wonnay; Hans & Sanii-Yahyai; Nahid
    Assignee(s): Warner-Lambert Company LLC
    A liquid pharmaceutical composition of a GABA analog comprising at least one polyhydric alcohol containing 2 to 6 carbon atoms having a pH of about 5.5 to about 7.0 and additionally a two-component liquid pharmaceutical composition comprising a first component comprising a powder mixture comprising a GABA analog and a solid polyhydric alcohol, and a second component comprising a liquid base are described, as well as methods to prepare the compositions and a method for treating cerebral diseases, including epilepsy, faintness attacks, hypokinesia and cranial traumas, neurodegenerative disorders, depression, mania and bipolar disorders, anxiety, panic, inflammation, renal colic, insomnia, gastrointestinal damage, incontinence, pain, including neuropathic pain, muscular pain, skeletal pain, and migraine using a therapeutically effective amount of the pharmaceutical compositions.
    Patent expiration dates:

    • May 28, 2022
      ✓ 
      Drug product


    • November 28, 2022
      ✓ 
      Pediatric exclusivity



See also...

  • Neurontin Consumer Information (Drugs.com)
  • Neurontin Consumer Information (Wolters Kluwer)
  • Neurontin Capsules Consumer Information (Wolters Kluwer)
  • Neurontin Solution Consumer Information (Wolters Kluwer)
  • Neurontin Consumer Information (Cerner Multum)
  • Neurontin Advanced Consumer Information (Micromedex)
  • Neurontin AHFS DI Monographs (ASHP)
  • Gabapentin Consumer Information (Drugs.com)
  • Gabapentin Consumer Information (Wolters Kluwer)
  • Gabapentin Capsules Consumer Information (Wolters Kluwer)
  • Gabapentin Enacarbil Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Gabapentin Solution Consumer Information (Wolters Kluwer)
  • Gabapentin Consumer Information (Cerner Multum)
  • FusePaq Fanatrex Advanced Consumer Information (Micromedex)
  • Gabapentin Advanced Consumer Information (Micromedex)
  • Gabapentin AHFS DI Monographs (ASHP)

No comments:

Post a Comment